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ABSTRACT 
 
Objective: Norwood and hybrid procedure are two options available for initial palliation of 
patients with hypoplastic left heart syndrome (HLHS). Our study aimed to assess potential 
differences in right ventricular (RV) function and pulmonary artery dimensions using cardiac 
magnetic resonance (CMR) in HLHS survivors.  
Methods: 42 Norwood (mean age 2.4±0.8) and 44 hybrid (mean age 2.0±1.0 years) patients 
were evaluated by CMR after stage II palliation prior to planned Fontan completion. Initial 
stage I Norwood procedure was performed using a modified Blalock-Taussig shunt while the 
hybrid procedure consisted of bilateral pulmonary artery banding and arterial duct stenting. 
Need for reinterventions and subsequent ouctomes were also assessed. 
Results: Norwood patients had larger RV end-diastolic dimensions (91±23 vs 80±31 ml/m2, 
p=0.004) and lower heart rate (90±15 vs 102±13, p<0.001) than hybrid patients. Both 
Norwood and hybrid patients showed preserved global RV pump function (59±9 vs 59±10 %, 
p=0.91) while RV strain, strain rate and intra-ventricular synchrony were superior in the 
Norwood group. Pulmonary artery size was reduced (lower lobe index 135 ± 81 vs 161 ± 70 
mm2/m2, p=0.02) and reintervention rate was significantly higher in the hybrid group whereas 
subsequent outcome did not differ significantly (p=0.24). 
Conclusions: Norwood and hybrid strategy were associated with equivalent and preserved 
global RV pump function while development of the pulmonary arteries and reintervention rate 
were superior using the Norwood approach. Impaired RV myocardial deformation as a 
potential marker of early RV dysfunction in the hybrid group may have a negative long-term 
impact in this population. 
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KEY QUESTIONS: 
What is already known about this subject? 
Compared to the Norwood approach, initial stage I palliation using the hybrid procedure may 
preserve RV function but also carries a higher risk of pulmonary arterial compromise. 
However, data about the effects of Norwood and hybrid procedure on RV function and 
vascular development in ‘standard risk’ HLHS patients are limited. 
 
What does this study add? 
Our study demonstrated that both Norwood and hybrid strategy were associated with 
preserved global RV pump function prior to Fontan completion while growth of the 
pulmonary arteries and reintervention rate were superior using the Norwood approach. 
Reduced RV myocardial deformation in the hybrid group may indicate early RV dysfunction.  
 
How might this impact on clinical practice? 
Stage I hybrid palliation strategy for ’standard risk’ HLHS patients was associated with 
preserved global RV function but reduced indices of RV myocardial performance. 
Advantageous pulmonary artery development and less reinterventions therefore suggest 
favourable effects using the Norwood approach.  
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INTRODUCTION 
Although initially considered as an alternative therapy in ‘high risk’ neonates,[1] some 
institutions have succeeded in adopting the hybrid procedure as the primary stage I palliation 
for all hypoplastic left heart syndrome (HLHS) patients.[2, 3, 4] Thy hybrid procedure 
includes bilateral pulmonary artery banding, stenting of the arterial duct and atrial septostomy 
in case of a restrictive interatrial communication.[5] In theory, the potential benefits of the 
hybrid strategy arise from the avoidance of early cardiopulmonary bypass in the first days of 
life thereby avoiding ischemic insult to the neonatal heart, brain and other organs. This may 
preserve right ventricular (RV) myocardial function in the long-term thereby leading to 
advantageous transplant-free survival. However, data comparing the hybrid strategy with the 
Norwood approach (modified Blalock-Taussig shunt) and/or the right ventricle-pulmonary 
artery conduit (Sano shunt) included either smaller groups of patients at one single institution 
[6, 7, 8, 9] or were obtained from larger national registries that only allow limited conclusions 
mainly due to substantial bias in patient selection and technical modifications varying among 
centres.[10, 11, 12]  
Our study aimed to assess potential differences in RV remodeling, reintervention rates and 
subsequent outcome of ‘standard risk’ HLHS patients who initially underwent the Norwood 
or the hybrid approach as the first-line stage I palliation strategy. Therefore, HLHS patients 
after stage II palliation from two european centres were evaluated using cardiac magnetic 
resonance (CMR) imaging to assess RV size, function and pulmonary artery dimensions as 
prior to planned Fontan completion.  
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MATERIALS AND METHODS 
Study population and design 
Ethical and institutional approval was obtained. Patients with HLHS who underwent a CMR 
study as part of their routine clinical preoperative assessment prior to Fontan completion with 
creation of a total cavopulmonary connection (TCPC) at Evelina London Children’s Hospital, 
United Kingdom (between 2008 and 2014) and the Pediatric Heart Centre, Giessen, Germany 
(between 2008 and 2015) were included after identification by the departmental databases. 
HLHS was defined as any combination of mitral stenosis or atresia with aortic stenosis or 
atresia where the left ventricle was not felt adequate at that point to support the systemic 
circulation.  
At Evelina London all patients with HLHS undergo a classical Norwood procedure unless 
they are high risk (<2.5kg, post-natal collapse with multi-organ dysfunction, intact or highly 
restrictive atrial septum, significant RV dysfunction, significant tricuspid regurgitation).[13] 
If patients are high risk, only then they are selected for the hybrid procedure. For this reason, 
only patients undergoing the primary Norwood Procedure at Evelina London were included. 
In Giessen, all patients undergo the hybrid procedure and are not pre-selected, and so the 
hybrid patients were taken from this institution.  Patients were excluded if clinical data and/or 
CMR studies were incomplete or of poor image quality. Clinical data were retrospectively 
obtained from hospital medical records. Standard two-dimensional echocardiographic images 
were analysed and tricuspid valve regurgitation was qualitatively graded as: °I=trivial/mild, 
°II=moderate and °III=severe. The review study protocol was approved by the local review 
boards of each institution. 
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Hybrid Stage I - III 
Details of the Giessen hybrid approach have recently been published in detail.[14] Briefly, the 
stage I approach consists of surgical bilateral pulmonary artery banding (bPAB), stenting of 
the arterial duct (PDA) and atrial septostomy within the first 10 postnatal days (Figure 1). At 
the age of 4-6 months, a comprehensive stage II operation is performed and includes aortic 
arch reconstruction, balloon dilatation and/or patch augmentation at sites of the PAB, 
atrioseptectomy and a bidirectional Glenn anastomosis. Stage III surgery is then completed by 
a TCPC typically performed at the age of 3-4 years using an extracardiac conduit placed 
between the vena cava inferior and the right pulmonary.[14]  
 
Norwood Stage I - III 
The Norwood stage I procedure at Evelina London consists of a size appropriate modified 
BTS (3.0/3.5/4.0 mm), atrioseptectomy with reconstruction of the aortic arch (Figure 1). 
Stage II is performed at 3-6 months of age as a hemi-Fontan with further stage III completion 
at 3-4 years of age with a lateral tunnel TCPC. While any stenosis in the right pulmonary 
artery is included in the hemi-Fontan operation, surgical intervention on the left pulmonary 
artery is avoided whenever possible. 
 
Cardiovascular magnetic resonance (CMR) acquisition and analysis 
With the exception of anaesthetic strategy, the CMR protocols at the two institutions were 
comparable and consisted of, amongst others, standard cine volumetric assessment of the 
single ventricle and contrast-enhanced angiographic assessment of the vasculature. 
CMR studies were performed on a 3-T system (Verio, Siemens, Erlangen, Germany) in 
hybrid and a 1.5-T scanner (Achieva, Philips Healthcare, Best, the Netherlands) in Norwood 
patients. Sedation using a combination of midazolam and propofol was applied in hybrid 
patients whereas the Norwood patients underwent general anaesthesia employing inhaled 
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sevofluorane and a low-dose remifentanyl infusion. A stack of short-axis slices from the base 
of the heart to the apex was used for quantification of RV volumes using gradient echo cine 
(GRE) sequences in free-breathing technique in the hybrid and a steady-state free precession 
(SSFP) cine sequence with short cessation of ventilation for the duration of each acquisition 
in the Norwood group. Sequence parameters were as follows (hybrid and Norwood, 
respectively): TR 56/3.6 ms, TE 2.5/1.8 ms, flip angle 12°/60°, slice thickness 5/4-6 mm, in 
plane image resolution 1.4x1.4x5.0/1.3x2.0x4-6 mm. A 3-dimensional (3D) contrast-
enhanced magnetic resonance angiographic (CE-MRA) scan was obtained in the coronal 
plane, using gadopentetate dimeglumine (Magnevist, Bayer, Leverkusen, Germany or 
Magnevist, Berlex Laboratories, Wayne, New Jersey) at a dose of 0.1-0.2 mmol/kg using the 
following parameters: slice thickness 1.2-1.4/1.2-1.7 mm, flip angle 19°/40°, generalized 
autocalibrating partially parallel acquisition imaging, with an acceleration factor of 2.  
 
Volumetry and vessel measurements  
End-diastolic and end-systolic volumes, stroke volumes and ejection fractions for the RV and 
LV (where present LV) were calculated by dedicated software (ARGUS, Siemens, Erlangen, 
Germany and Viewforum EWS Version 2.0, Philips Healthcare, Best, the Netherlands).[15]  
User-defined multiplanar reformatted (MPR) images were obtained using dedicated software 
(OsiriX Viewer). The indexed lower lobe index (LLI) was used for evaluation of pulmonary 
artery size and was calculated as the sum of the cross-sectional areas of the lower lobe branch 
of the right and left pulmonary arteries. Aortic dimensions were measured at predefined levels 
as displayed in Figure 2A. All parameters were indexed to body surface area (BSA). 
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CMR feature tracking for the assessment of myocardial strain, strain rate and 
synchrony 
CMR feature tracking (CMR-FT) allows quantitative assessment of myocardial strain derived 
from standard short axis and 4-chamber cine CMR images using CMR-FT software (TomTec 
Imaging Systems, Unterschleissheim, Germany). The values of global peak strain and strain 
rate were recorded and intraventricular synchrony was assessed from the time to peak analysis 
as the maximum wall delay between the 6 segments as well as the standard deviation of the 6 
segments (Figure 2B). RV diastolic function was derived from the global circumferential 
strain rate curve with determination of the early diastolic strain rate wave.  
 
Statistical analysis  
All continuous variables were tested for normality using the Kolmogorov-Smirnov test and 
are presented as mean with standard deviation. Comparisons between the Norwood and the 
hybrid group were made with the Student t-test, the Mann-Whitney U test or the Fisher’s 
exact test, as appropriate. Pearson’s correlation coefficient was used to analyse simple linear 
relationships between different variables. Kaplan–Meier survival analysis was conducted with 
definition of end point as the composite of all-cause mortality and heart transplantation. 
Analysis was performed using GraphPad statistical software package (San Diego, California, 
USA). A p value ≤0.05 was considered statistically significant. The intra- and interobserver 
variability for single RV strain and synchrony measurements were assessed using the 
coefficient of variation (CV, defined as the standard deviation of the differences divided by 
the mean). 
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RESULTS 
Patient characteristics and clinical findings 
The study consisted of 44 hybrid patients (mean age 2.0 ± 1.0 years, 14 females) and 42 
Norwood patients (mean age 2.4 ± 0.8 years, p=0.08, 15 females). Both groups were age and 
sex matched. There was no difference in the underlying HLHS subtype diagnosis, frequency 
of antenatal diagnosis, preterm birth, birth weight and severity of tricuspid valve regurgitation 
Table 1).  
 
Reinterventions 
A significant higher rate of reinterventions due to pulmonary artery stenosis after stage II was 
necessary in the hybrid group (19 (43%) vs 1 (2%), p=0.0003) (Table 2). Reinterventions 
after stage I due to obstruction of the stented arterial duct/inadequate tightness of the PAB 
(hybrid) or surgical revision of the BT-shunt (Norwood) were also higher in the hybrid group 
(11 (25%) vs 1 (2%), p=0.04) and repeated atrial septostomy was performed in 13 (30%) 
hybrid and in 1 (2%) Norwood patients (p=0.0008).  
 
Volumetry 
Norwood patients had significantly higher RV end-diastolic (91.2 ± 23.0 vs 80.9 ± 31.7 
ml/m2; p=0.004) and similar end-systolic volumes (38.1 ± 16.5 vs 34.8 ± 22.9 ml/m2, p=0.07) 
(Figure 3). Due to a significantly higher heart rate in the hybrid group (102 ± 13 vs 90 ± 15 
beats per minute; p<0.001) cardiac output was almost similar in the two groups (4.9 ± 1.2 vs 
4.7 ± 1.2 l/min/m2, p=0.44) RV ejection fraction (EF) was preserved in both groups and 
showed no significant difference (59.4 ± 10.3 vs 59.2 ± 9.0 %, p=0.91) (Table 3). 
 
Feature tracking analysis including synchrony measurements 
Norwood patients showed significant more negative RV longitudinal (LS) (-16.5 ± 5.5 vs -
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13.2 ± 5.9 %, p=0.008), circumferential (CS) (-18.4 ± 5.6 vs -14.7 ± 5.6 %; p=0.001), and 
radial strain (RS) values (21.5 ± 9.5 vs 13.9 ± 8.7 %; p=0.0002) than hybrid patients (Table 3 
and Figure 3). Systolic longitudinal strain rate (LSR -1.25 ± 0.60 vs -1.05 ± 0.47 1/s, 
p=0.027) and radial strain rate (RSR 1.17 ± 0.40 vs 1.03 ± 0.37 1/s, p=0.05) values were also 
higher in the Norwood group. Early diastolic circumferential strain rate showed no significant 
difference between the two groups (1.5 ± 0.7 vs 1.3 ± 0.5 1/s, p=0.09). RV circumferential 
and radial intra-ventricular synchrony was found to be significantly lower in the hybrid group.  
Heart rate was significantly related to RV-LS (r=0.27, p=0.01) and RV–CS (r=0.31, p=0.004). 
Indexed RV stroke volume showed significant correlations with RV-CS (r=0.34, p=0.0014) 
and RV–RS (r=0.39, p=0.0003).  
 
CMR-Angiography for evaluation of pulmonary artery and aortic dimensions 
Measurement of the lower lobe index (LLI) was possible in 30 patients (68%) in the hybrid 
group (analysis was not possible in 14 patients due to stent artefacts) and in 39 patients (93%) 
in the Norwood group. While right LLI did not reach a statistical significant difference (82 ± 
50 vs 93 ± 79 mm2/m2; p=0.08) the left LLI was significantly decreased in the hybrid group 
(55 ± 31 vs 70 ± 45 mm2/m2; p=0.037) resulting in a lower total LLI in this group (135 ± 81 
vs 161 ± 70 mm2/m2; p=0.021) (Figure 2A and Table 4). 
No differences in aortic dimensions were found and there was no evidence of aortic arch 
obstruction or relevant coarctation in any patient (Table 4).  
 
Further palliation and outcome 
In the Norwood group, one patient died between stage II and III due to severe airway issues 
while the remaining 41 patients underwent stage III (Figure 1). Two of these patients died in 
the postoperative period (one from ultimate bowel perforation and the other from 
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overwhelming sepsis). Of the 44 hybrid patients, three patients underwent cardiac 
transplantation due to severe RV dysfunction prior to stage III. Thirty-five patients have 
undergone stage III. One patient died during the postoperative period due to pulmonary 
thromboembolic complications with the need for extracorporeal membrane oxygenation. The 
mean follow-up interval after stage III was significantly longer in the Norwood group (3.7 ± 
1.4 years) than in the hybrid group (2.0 ± 2.1 years; p<0.0001) with no further adverse events 
in both groups. Kaplan-Meier survival analysis (Figure 4) showed no statistical difference in 
mid-term outcome between the two groups (p=0.24).  
 
 
DISCUSSION 
Our study assessed the pattern of RV remodeling, development of the pulmonary arteries, 
reinterventions and outcome in HLHS-patients prior to planned Fontan surgery who were 
initially palliated either by Norwood or hybrid strategy. Importantly, these approaches were 
used as the first-line therapy in ‘standard risk’ HLHS-patients in the respective centre. While 
global RV pump function was found to be preserved in both groups, hybrid patients showed 
lower RV strain and strain rate values, smaller pulmonary arteries and a more reinterventions 
than Norwood patients whereas subsequent outcomes did not differ significantly.  
 
Single right ventricular size and function  
Preservation of single RV function represents a key factor during staged palliation of children 
with HLHS.[16] Recent single-institution studies assessed RV function qualitatively and 
demonstrated a profound impact of ventricular dysfunction on atrioventricular valve 
competence and transplant-free survival while initial Norwood or hybrid strategy seemed to 
be unrelated to the presence of RV impairment. [6, 7] A further study by Grotenhuis and 
colleagues assessed RV properties by echocardiography in HLHS-patients throughout 
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different stages of palliation [17] which found only minor differences in some indices of RV 
function leading to the conclusion that the used surgical strategy may not have a decisive 
effect on intrinsic myocardial and tricuspid valve function.  
By quantifying RV function with CMR, our study found equivalent and preserved ejection 
fraction in both groups creating optimal preconditions for further Fontan completion. 
However, reduced systolic RV strain and strain rate values as well as a higher degree of 
intraventricular dysynchrony are indicative of subclinical myocardial dysfunction and 
unfavourable remodeling in hybrid patients. While in both strategies the myocardium is 
subjected to volume loading and likely ischemia prior to stage II, the mechanisms and time 
points of myocardial insult differ.[7] The hybrid strategy shifts the risks of major open-heart 
surgery from the neonatal period to an older age, which may be beneficial given the known 
vulnerability of neonatal myocardium to ischemia caused by cardiopulmonary bypass. 
However, the risks of the hybrid procedure include impaired myocardial blood supply due to 
retrograde perfusion of the hypoplastic aortic arch and ascending aorta.[18, 19] Although 
survival analysis showed no statistical significance, the evolution of severe RV dysfunction in 
three patients in the hybrid group with subsequent need for cardiac transplantation support 
this hypothesis. Importantly, unlike the Sano strategy, both classical Norwood and hybrid 
strategies avoid a ventriculotomy thereby preventing potential irrerversible myocardial 
injury.[16, 20, 21]  
The observed variations in heart rate, volumes, strain and synchrony measurements, must also 
be interpreted with regards to the different anaesthetic strategies used which are known to 
have substantial hemodynamic effects. The observed heart rate and stroke volume 
dependency of the strain values clearly support this suggestion. In contrast, RV strain rate is 
known to be a more load-independent parameter of RV function in HLHS-patients as recently 
shown in an invasive conductance-catheter study.[22] The lower systolic strain rate values in 
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the hybrid group therefore reflects impaired intrinsic RV myocardial performance that cannot 
be explained by altered loading conditions due to anaesthesia.     
          
Reinterventions                 
A number of studies have already shown that pulmonary artery stenosis occurs frequently in 
HLHS patients undergoing the hybrid procedure.[14, 23, 24] This can be explained by the 
previous banding of the pulmonary arteries and their subsequent need for surgical 
reconstruction at comprehensive stage II. Although branch pulmonary artery stenosis and 
distorsion has also been reported using the Norwood approach, our results confirm previous 
observations that revealed a higher pulmonary artery reintervention rate associated with the 
hybrid procedure. [6, 23] Importantly, the need for reinterventions after hybrid stage I was 
significantly higher, mainly due to obstruction of the stented arterial duct and repeated 
percutaneous atrial septostomy to guarantee an unobstructed interatrial communication. In 
addition to the well-known risks associated with any transcatheter intervention, such multiple 
catheterization procedures will lead to a higher radiation burden over lifetime.  
 
Pulmonary artery and aortic size 
By assessing the lower lobe index as a measure of central pulmonary artery growth, Norwood 
patients showed superior development of their pulmonary arteries. This finding is in 
accordance with previous reports [6, 25] and suggests that even in the absence of significant 
branch pulmonary artery stenosis, pulmonary artery development is affected by previous 
restriction of pulmonary blood flow by bilateral PA banding. Considering that patients with 
prior stents were not included in the analysis due to imaging artefacts, the difference in 
pulmonary artery size between the two groups is probably even more distinct. It must also be 
taken into account that the surgical techniques to create a superior cavopulmonary connection 
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differed between the two groups which potentially leads to variable pulmonary arterial 
distortion during growth. No significant difference was seen in the short term after TCPC, but 
given the importance of adequate branch pulmonary artery size in the Fontan circulation, 
longer-term differences need to be assessed.  
Despite preceding stent implantation in the arterial duct, quality of aortic arch reconstruction 
following comprehensive stage II was achievable with a low reintervention rate in the hybrid 
group. Furthermore, aortic dimensions measured at different levels showed equivalent sizes 
suggesting that both strategies prepare adequate aortic architecture at pre-Fontan stage.  
 
Study limitations 
Quantification of ventricular volumes by CMR cine imaging is influenced by the used the 
type of sequence. SSFP imaging overestimates ventricular volumes compared to GRE 
sequences [26, 27, 28] suggesting that differences in RV volume may also be due to the 
choice of imaging protocols rather than treatment methodology. Ventricular function (i.e. 
ejection fraction), however, is affected only in a minor way by the applied sequence [27, 28, 
29].  
The retrospective and non-randomized nature of this study resulted in a bias in patient 
selection and therefore limits further interpretation of the presented data. In particular, 
differences in early mortality and morbidity between the groups prior to stage II may thus be 
missed and may affect the results.[13] [14] Importantly, although hybrid patients were not 
pre-selected in their institution, risk-profiles between the two groups were comparable.  
The dual-centre design may also impose a bias as some of the differences detected between 
the groups may be more related to individual institutional practice rather than representing a 
real effect of the procedure. Although the two groups were well matched, differences in age 
(for example earlier stage II volume unloading surgery in the hybrid group) and type of 
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surgical procedures, management protocols, drug therapy as well as indication and type of 
reintervention could have influenced the results.  
 
CONCLUSIONS 
Norwood and hybrid strategy as initial palliation of ‘standard risk’ HLHS patients were 
associated with equivalent and preserved global RV pump function while development of the 
pulmonary arteries and reintervention rate were superior using the Norwood approach. 
Impaired RV myocardial deformation as a potential marker of early RV dysfunction in the 
hybrid group may have a long-term negative impact in this population.  
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Table legends 
Table 1 
Demographic data of the study population 
Variable Hybrid Norwood 
Significance 
(p-value) 
Patients, n 44 42 
 
Male/Female 30/14 27/15 0.82 
Body weight, kg 11.5 ± 3.2 12.3 ± 3.3 0.15 
BSA (m2) 0.52 ± 0.11 0.55 ± 0.07 0.14 
Age at study, years 2.0 ± 1.0 2.4 ± 0.8 0.08 
Diagnosis  
   
Hypoplastic left heart syndrome 
  
0.88 
   Mitral atresia/aortic atresia 22 21 
 
   Mitral atresia/aortic stenosis 2 2 
 
   Mitral stenosis/aortic atresia  10 7 
 
   Mitral stenosis/aortic stenosis 10 12 
 
Age at stage I, days 4.0 (1 - 47) 4.0 (1 – 66 0.11 
Age at stage II, months 4.2 ± 1.6 5.4 ± 1.7 <0.001 
Follow-up since stage II, months 19.8 ± 12.7 24.3 ± 8.7 0.06 
Antenatal diagnosis, n (%) 32 (73) 33 (79) 0.62 
Preterm (<37 week gestation), n 2 2 1.0 
Birth weight, g 3188 ± 738 3100 ± 401 0.41 
Transcutaneous oxygen saturation, % 84.1 ± 4.1 82.2 ± 3.9 0.16 
 18 
 
 
  
Tricuspid valve regurgitation, °I/°II/°III, n 36/7/1 36/5/1 0.87 
BSA, body surface area, MA, mitral atresia; MS, mitral stenosis; AA, aortic atresia; AS, aortic 
stenosis; data are presented as mean and 1 standard deviation. 
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Table 2 
Reinterventions in the two study groups 
Variable 
Hybrid           
n=44 
Norwood       
n=42 
Significanc
e (p-value) 
Pulmonary artery interventions (after stage II) 
   
     BAP, n (%) 5 (11) 0 (0) 0.05 
     Stent, n (%) 14 (32) 1 (2) 0.0003 
Collateral coil occlusion (after stage II), n (%) 6 (14) 2 (5) 0.27 
Coarctation dilation/stent (after stage II), n (%) 2 (5) 0 (0) 0.49 
Reintervention PDA/PAB or BTS (after stage I), n (%) 11 (25) 3 (8) 0.04 
ASD intervention (after stage I), n (%) 13 (30) 1 (2) 0.0008 
TV repair (after stage II), n (%) 1 (3) 1 (2) 1.0 
BAP, balloon angioplasty; PDA, persistent ductus arteriosus; PAB, pulmonary artery banding; 
BTS, modified Blalock-Taussig shunt;  ASD, atrial septal defect; TV, tricuspid valve. 
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Table 3 
Results of the CMR study and the feature tracking (FT) analysis including synchrony 
measurements 
Variable 
Hybrid           
n=44 
Norwood       
n=42 
Significance 
(p-value) 
CMR 
   
HR, /min 102 ± 13 90 ± 15 <0.001 
EDVi, ml/m2 80.9 ± 31.7 91.2 ± 23.0 0.004 
ESVi, ml/m2 34.8 ± 22.9 38.1 ± 16.5 0.07 
SVi, ml/m2 46.0 ± 11.9 53.1 ± 12.4 0.002 
EF, % 59.2 ± 9.0 59.4 ± 10.3 0.91 
CI, l/min/m2 4.7 ± 1.2 4.8 ± 1.2 0.44 
    
CMR-FT 
   
LS, % -13.2 ± 5.9 -16.5 ± 5.5 0.008 
LSR, 1/s -1.05 ± 0.47 -1.25 ± 0.60 0.027 
CS, % -14.7 ± 5.6 -18.4 ± 5.6 0.001 
CSR, 1/s -1.11 ± 0.44 -1.17 ± 0.36 0.41 
RS, % 13.9 ± 8.7 21.5 ± 9.5 0.0002 
RSR, 1/s 1.03 ± 0.37 1.17 ± 0.40 0.05 
Early diastolic CSR, 1/s 1.3 ± 0.5 1.5 ± 0.7 0.09 
    
Intraventricular synchrony 
   
LS 
   
      Maximum wall delay (ms) 176 ± 114 154 ± 80 0.39 
 21 
      SD (time to peak) (ms) 93 ± 42 83 ± 37 0.25 
CS 
   
      Maximum wall delay (ms) 246 ± 131 133 ± 66 <0.001 
      SD (time to peak) (ms) 96 ± 56 51 ± 23 <0.0001 
RS 
   
      Maximum wall delay (ms) 256 ± 150 140 ± 106 <0.0001 
      SD (time to peak) (ms) 99 ± 60 58 ± 47 0.0002 
EDV, enddiastolic volume; ESV, endsystolic volume; SV, stroke volume; EF, ejection 
fraction; FT, feature tracking; LS, longitudinal strain; LSR, longitudinal strain rate; 
CS, circumferential strain; CSR, circumferential strain rate; RS, radial strain; RSR, 
radial strain rate; data are presented as mean ± 1 standard deviation (SD). 
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Table 4 
Results of the angiographic size of the pulmonary arteries and the aorta at predefined levels 
Variable 
Hybrid           
n=44 
Norwood       
n=42 
Significance 
(p-value) 
CMR angiography 
   
Right LLI, mm2/m2 82 ± 50 93 ± 78 0.09 
Left LLI, mm2/m2 55 ± 31 70 ± 35 0.037 
LLI total, mm2/m2 135 ± 81 161 ± 70 0.021 
Native aorta, mm2/m2 92 ± 103 93 ± 78 0.30 
Neo aorta, mm2/m2 656 ± 183 658 ± 187 0.96 
Ascending aorta, mm2/m2 595 ± 236 555 ± 184 0.38 
Transverse arch, mm2/m2 476 ± 285 361 ± 151 0.13 
Isthmus, mm2/m2 116 ± 60 136 ± 42 0.16 
Descending aorta, mm2/m2 103 ± 50 100 ± 28 0.59 
APC, n (%) 8 (18) 8 (20) 1.0 
LLI, lower lobe index; APC, aortopulmonary collaterals; data are presented as mean 
± 1 standard deviation. 
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Figure legends 
 
Figure 1 
Flow diagram displaying the various types of procedures, time points and clinical outcomes 
for HLHS palliation in the Giessen hybrid group and the London Norwood group.  
HLHS, hypoplastic left heart syndrome; PA, pulmonary artery; mBT, modified Blalock-
Taussig shunt; PDA, persistent arterial ductus arteriosus; CMR, cardiac magnetic resonance; 
n, number of patients; HTx, cardiac transplantation 
 
Figure 2 
Cardiac magnetic resonance (CMR) study 
A Multiplanar reformatted (MPR) images of the branch pulmonary arteries (left) and the 
reconstructed aortic arch (right) from contrast-enhanced magnetic resonance angiography 
were used for assessment of the cross sectional areas right and left lower lobe index and aortic 
dimensions at predefined levels: 1. neo and native aortic root, 2. ascending aorta, 3. transverse 
arch after origin of the left common carotid artery, 4. aortic isthmus, 5. descending aorta. 
B Feature tracking (FT) analysis of the single RV in the midpapillary short-axis view (for the 
assessment of circumferential and radial strain; upper panel) and in the ‘4-chamber view’ (for 
the assessment of longitudinal strain; lower panel). After manually placing points along the 
ventricular endocardium in a single frame, the software algorithm follows this border 
throughout the cardiac cycle automatically and calculates strain/strain rate versus time for 
each of 6 segments. 
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Figure 3 
Box-and-whiskers plots for the key variables of the CMR study. The central line represents 
the median with the boxes representing the 1st and 99th percentiles.  
HR, heart rate; RV, right ventricle; EF, ejection fraction; LS, longitudinal strain; CS, 
circumferential strain; LSR, longitudinal strain rate.  
 
 
Figure 4 
Kaplan–Meier survival curves of the hybrid (blue line) and Norwood (orange line) group for 
the composite endpoint that consisted of all-cause mortality and heart transplantation 
(p=0.24). Displayed on the x-axis is the time (months) that has passed since the cardiac 
magnetic resonance (CMR) study prior to Fontan completion. 
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Online Supplement 
Intra- and interobserver variability of single right ventricular global strain and synchrony 
measurements. One investigator blinded to the clinical and all other CMR data (P.H.) 
performed the feature-tracking analysis and after an interval of 12 weeks, both this observer 
and a second experienced observer (H.L.) repeated the feature-tracking analysis on the same 
images of 20 randomly selected subjects (10 Norwood and 10 hybrid patients). An 
appropriate analysis of the single RV using CMR-FT was feasible in all HLHS patients. 
Among all strain and synchrony parameters, global radial strain and radial synchrony showed 
the poorest reproducibility. 
 
Variable Intraobserver CV (%) Interobserver CV (%) 
Longitudinal strain (LS) 3.0 4.5 
Circumferential strain (CS) 4.9 7.3 
Radial strain (RS) 8.4 15.7 
Early diastolic strain rate 3.2 4.9 
LS SD time to peak 5.4 8.4 
CS SD time to peak 8.2 12.5 
RS SD time to peak 9.9 16.7 
CV, coefficient of variation; SD, standard deviation. 
  
 26 
Acknowledgments: None. 
 
Sources of Funding: This study was supported by the Doris-Haag Stiftung, Frankfurt am 
Main, Germany and the Willy Robert Pitzer Stiftung, Bad Nauheim, Germany. This study has 
also received funding by the Department of Health through the National Institute for Health 
Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' 
NHS Foundation Trust in partnership with King's College London and King’s College 
Hospital NHS Foundation Trust. The Division of Imaging Sciences receives also support as 
the Centre of Excellence in Medical Engineering (funded by the Wellcome Trust and EPSRC; 
grant number WT 088641/Z/09/Z) as well as the BHF Centre of Excellence (British Heart 
Foundation award RE/08/03).  
 
Conflict of interest  
The authors declare that they have no conflict of interest. 
 
Contributorship statement 
HL, HB, TH, CA, CY, DS and GG have contributed to the conception and design of the 
study. 
HL, MN, JW, PH, CS, CA, DA, RR and HA have contributed to the acquisition of data, 
analysis and interpretation of the data. 
HL, JB, TH, DS and GG have contributed to the drafting of the article and have revised it 
critically for important intellectual content. 
 
Statement 
The Corresponding Author has the right to grant on behalf of all authors and does grant on 
behalf of all authors, an exclusive licence (or non exclusive for government employees) on a 
 27 
worldwide basis to the BMJ Publishing Group Ltd and its Licensees to permit this article (if 
accepted) to be published in HEART editions and any other BMJPGL products to exploit all 
subsidiary rights. 
 
  
 28 
REFERENCES 
1 Bacha EA, Daves S, Hardin J, et al. Single-ventricle palliation for high-risk neonates: 
the emergence of an alternative hybrid stage I strategy. The Journal of thoracic and 
cardiovascular surgery 2006;131:163-71 e2. 
2 Galantowicz M, Cheatham JP, Phillips A, et al. Hybrid approach for hypoplastic left 
heart syndrome: intermediate results after the learning curve. The Annals of thoracic surgery 
2008;85:2063-70; discussion 70-1. 
3 Schranz D, Bauer A, Reich B, et al. Fifteen-year Single Center Experience with the 
"Giessen Hybrid" Approach for Hypoplastic Left Heart and Variants: Current Strategies and 
Outcomes. Pediatric cardiology 2014. 
4 Caldarone CA, Benson L, Holtby H, et al. Initial experience with hybrid palliation for 
neonates with single-ventricle physiology. The Annals of thoracic surgery 2007;84:1294-300. 
5 Gibbs JL, Wren C, Watterson KG, et al. Stenting of the arterial duct combined with 
banding of the pulmonary arteries and atrial septectomy or septostomy: a new approach to 
palliation for the hypoplastic left heart syndrome. British heart journal 1993;69:551-5. 
6 Baba K, Kotani Y, Chetan D, et al. Hybrid versus Norwood strategies for single-
ventricle palliation. Circulation 2012;126:S123-31. 
7 Chetan D, Kotani Y, Jacques F, et al. Surgical palliation strategy does not affect 
interstage ventricular dysfunction or atrioventricular valve regurgitation in children with 
hypoplastic left heart syndrome and variants. Circulation 2013;128:S205-12. 
8 Brescia AA, Jureidini S, Danon S, et al. Hybrid versus Norwood procedure for 
hypoplastic left heart syndrome: contemporary series from a single center. The Journal of 
thoracic and cardiovascular surgery 2014;147:1777-82. 
9 Pizarro C, Derby CD, Baffa JM, et al. Improving the outcome of high-risk neonates 
with hypoplastic left heart syndrome: hybrid procedure or conventional surgical palliation? 
European journal of cardio-thoracic surgery : official journal of the European Association 
for Cardio-thoracic Surgery 2008;33:613-8. 
10 Karamlou T, Overman D, Hill KD, et al. Stage 1 hybrid palliation for hypoplastic left 
heart syndrome--assessment of contemporary patterns of use: an analysis of The Society of 
Thoracic Surgeons Congenital Heart Surgery Database. The Journal of thoracic and 
cardiovascular surgery 2015;149:195-201, 2 e1. 
11 Wilder TJ, McCrindle BW, Hickey EJ, et al. Is a hybrid strategy a lower-risk 
alternative to stage 1 Norwood operation? The Journal of thoracic and cardiovascular 
surgery 2017;153:163-72 e6. 
12 Malik S, Bird TM, Jaquiss RD, et al. Comparison of in-hospital and longer-term 
outcomes of hybrid and Norwood stage 1 palliation of hypoplastic left heart syndrome. The 
Journal of thoracic and cardiovascular surgery 2015;150:474-80 e2. 
13 Lloyd DF, Cutler L, Tibby SM, et al. Analysis of preoperative condition and interstage 
mortality in Norwood and hybrid procedures for hypoplastic left heart syndrome using the 
Aristotle scoring system. Heart 2014;100:775-80. 
14 Yerebakan C, Valeske K, Elmontaser H, et al. Hybrid therapy for hypoplastic left heart 
syndrome: Myth, alternative, or standard? The Journal of thoracic and cardiovascular 
surgery 2015. 
15 Bellsham-Revell HR, Tibby SM, Bell AJ, et al. Serial magnetic resonance imaging in 
hypoplastic left heart syndrome gives valuable insight into ventricular and vascular 
adaptation. Journal of the American College of Cardiology 2013;61:561-70. 
16 Newburger JW, Sleeper LA, Frommelt PC, et al. Transplantation-free survival and 
interventions at 3 years in the single ventricle reconstruction trial. Circulation 2014;129:2013-
20. 
 29 
17 Grotenhuis HB, Ruijsink B, Chetan D, et al. Impact of Norwood versus hybrid 
palliation on cardiac size and function in hypoplastic left heart syndrome. Heart 
2016;102:966-74. 
18 Hsia TY, Cosentino D, Corsini C, et al. Use of mathematical modeling to compare and 
predict hemodynamic effects between hybrid and surgical Norwood palliations for 
hypoplastic left heart syndrome. Circulation 2011;124:S204-10. 
19 Egan MJ, Hill SL, Boettner BL, et al. Predictors of retrograde aortic arch obstruction 
after hybrid palliation of hypoplastic left heart syndrome. Pediatric cardiology 2011;32:67-
75. 
20 Frommelt PC, Gerstenberger E, Cnota JF, et al. Impact of initial shunt type on cardiac 
size and function in children with single right ventricle anomalies before the Fontan 
procedure: the single ventricle reconstruction extension trial. Journal of the American College 
of Cardiology 2014;64:2026-35. 
21 Wong J, Lamata P, Rathod RH, et al. Right ventricular morphology and function 
following stage I palliation with a modified Blalock-Taussig shunt versus a right ventricle-to-
pulmonary artery conduit. European journal of cardio-thoracic surgery : official journal of 
the European Association for Cardio-thoracic Surgery 2016. 
22 Schlangen J, Petko C, Hansen JH, et al. Two-dimensional global longitudinal strain 
rate is a preload independent index of systemic right ventricular contractility in hypoplastic 
left heart syndrome patients after Fontan operation. Circulation Cardiovascular imaging 
2014;7:880-6. 
23 Rahkonen O, Chaturvedi RR, Benson L, et al. Pulmonary artery stenosis in hybrid 
single-ventricle palliation: High incidence of left pulmonary artery intervention. The Journal 
of thoracic and cardiovascular surgery 2015;149:1102-10 e2. 
< 
25 Davies RR, Radtke WA, Klenk D, et al. Bilateral pulmonary arterial banding results in 
an increased need for subsequent pulmonary artery interventions. The Journal of thoracic and 
cardiovascular surgery 2014;147:706-12. 
26 Alfakih K, Thiele H, Plein S, et al. Comparison of right ventricular volume 
measurement between segmented k-space gradient-echo and steady-state free precession 
magnetic resonance imaging. Journal of magnetic resonance imaging : JMRI 2002;16:253-8. 
27 Hudsmith LE, Petersen SE, Tyler DJ, et al. Determination of cardiac volumes and 
mass with FLASH and SSFP cine sequences at 1.5 vs. 3 Tesla: a validation study. Journal of 
magnetic resonance imaging : JMRI 2006;24:312-8. 
28 Grothues F, Boenigk H, Graessner J, et al. Balanced steady-state free precession vs. 
segmented fast low-angle shot for the evaluation of ventricular volumes, mass, and function at 
3 Tesla. Journal of magnetic resonance imaging : JMRI 2007;26:392-400. 
29 Malayeri AA, Johnson WC, Macedo R, et al. Cardiac cine MRI: Quantification of the 
relationship between fast gradient echo and steady-state free precession for determination of 
myocardial mass and volumes. Journal of magnetic resonance imaging : JMRI 2008;28:60-6. 
 
